- Home
- Products
Zepzelca (Lurbinectedin)
Zepzelca (Lurbinectedin)
- Medicine Name: Zepzelca
- Generic Name: Lurbinectedin
- Dosage Form & Strength: 4 mg lyophilized powder for injection (single-dose vial)
- Manufactured By:Jazz Pharmaceuticals Inc.
Zepzelca is a Trop-2-directed alkylating agent indicated for the treatment of adults with metastatic small cell lung cancer (SCLC) that has progressed after or during platinum-based chemotherapy.
Recommended Dosage:
- 3.2 mg/m² administered via IV infusion over 60 minutes every 21 days
- Continue until disease progression or unacceptable toxicity
- Do not substitute with other chemotherapy agents
- Start treatment only if ANC ≥ 1,500/mm³ and platelets ≥ 100,000/mm³
- Myelosuppression: Monitor CBC (neutrophils, platelets) before each dose
- Hepatotoxicity: Monitor ALT, AST, bilirubin before and during treatment
- Avoid grapefruit and grapefruit juice during treatment
- Women should not conceive or breastfeed during and for at least 14 days after final dose
- Inform your doctor of all herbal supplements or concurrent medications
Documents Required for Import to India
- Valid prescription from a certified oncologist
- Diagnostic reports indicating SCLC diagnosis
- Government-issued ID proof (patient name must match)
Order Confirmation
- Confirmed only after all documentation is submitted and import permit (if applicable) is received.
Availability in India
Zepzelca can be made available in major Indian cities including:
Mumbai, Delhi, Noida, Gurgaon, Chennai, Kolkata, Hyderabad, Bangalore, Pune, Ahmedabad, Lucknow, Chandigarh, Jaipur, Ludhiana, Srinagar, Jammu and more.
📞 To Check Price or Place an Order:
Call/WhatsApp: +91-99675 15602
Email: info@globalraremeds.com
- Sourced from certified suppliers in the USA, Europe, Canada, and Australia
- Prescriptions are verified by registered pharmacists
- Shipped from our central fulfillment center in Ambernath, Thane District
- Compliant with WHO-GDP and ISO 9001:2008 standards
What is the generic name for Zepzelca®?
Lurbinectedin
Who manufactures Zepzelca®?
Jazz Pharmaceuticals Inc.
Is Zepzelca® FDA approved?
Yes. Approved on June 15, 2020
What does Zepzelca treat?
Used to treat metastatic small cell lung cancer (SCLC) after progression on platinum-based chemotherapy
What form is Zepzelca® supplied in?
Single-dose 4 mg lyophilized powder vial for intravenous use
What are the most common side effects?
Fatigue, nausea, cough, appetite loss, anemia, low white cell counts, vomiting, diarrhea, electrolyte imbalances, muscle/joint pain, breathing difficulty
How much does Zepzelca® cost in India?
Prices vary based on sourcing location and delivery urgency.
👉 For the latest price: +91-99675 15602 | info@globalraremeds.com
How should Zepzelca be stored?
Store at 2°C to 8°C. Do not freeze.
Handle as a hazardous drug – use appropriate disposal protocols.
Can I buy Zepzelca® online in India?
Yes. Only from WHO-GDP & ISO-certified distributors like Global Rare Meds
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
